Advances in Cancer Treatment
Received Date: Jan 02, 2023 / Published Date: Jan 30, 2023
Abstract
Schreiber and his group provided in experimental evidence supporting the concept of immune surveillance for cancer. However, they had also suggested that tumors developed in the presence of healthy immune system are less immunogenic compared to those that are developed in an immune-compromised host makes the immune system paradoxical in favouring the eventual growth of tumors leading to the escape of the immune response that is better able to escape the immune response
Citation: Sepulveda I (2023) Advances in Cancer Treatment. Adv Cancer Prev 7: 150.
Copyright: © 2023 Sepulveda I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
51ºÚÁϳԹÏÍø Journals
Article Usage
- Total views: 1076
- [From(publication date): 0-2023 - Jun 23, 2025]
- Breakdown by view type
- HTML page views: 715
- PDF downloads: 361
